Vectors Research Management’s Amgen AMGN Stock Holding History

Vectors Research Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-388	Closed	-$94K	–	151
2022 Q2	$94K	Buy	388 +35	+10%	+$8.58K	0.02%	179
2022 Q1	$85K	Sell	353 -134	-28%	-$30.8K	0.02%	188
2021 Q4	$110K	Buy	487 +85	+21%	+$17.9K	0.02%	198
2021 Q3	$85K	Hold	402	–	–	0.02%	209
2021 Q2	$98K	Hold	402	–	–	0.03%	192
2021 Q1	$100K	Buy	402 +94	+31%	+$22.4K	0.03%	183
2020 Q4	$71K	Buy	308 +265	+616%	+$61.1K	0.02%	182
2020 Q3	$11K	Hold	43	–	–	﹤0.01%	291
2020 Q2	$10K	Hold	43	–	–	﹤0.01%	293
2020 Q1	$9K	Hold	43	–	–	﹤0.01%	300
2019 Q4	$10K	Sell	43 -1,025	-96%	-$226K	﹤0.01%	342
2019 Q3	$207K	Sell	1,068 -233	-18%	-$44.7K	0.1%	109
2019 Q2	$240K	Sell	1,301 -67	-5%	-$12K	0.13%	94
2019 Q1	$260K	Sell	1,368 -130	-9%	-$24.8K	0.15%	90
2018 Q4	$292K	Buy	1,498 +370	+33%	+$72.2K	0.14%	92
2018 Q3	$209K	Buy	+1,128	New	+$222K	0.13%	99

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vectors Research Management's AMGN Position: Q3 2022 in Review

Vectors Research Management sold out of Amgen (AMGN) in Q3 2022, closing a stake of 388 shares — an estimated $94K sold.

Vectors Research Management first reported a position in AMGN in Q3 2018 and held it in 16 quarters. The position peaked at $292K in Q4 2018. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Vectors Research Management reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 388 Amgen shares in Q3 2022, an estimated $94K.
Vectors Research Management first reported a position in Amgen in Q3 2018 and held it in 16 quarters.
Vectors Research Management's Amgen position peaked at $292K in Q4 2018.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.